Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
Aids in management of patients with bladder cancer patients in conjunction with cystoscopy. Qualitative assay detects bladder tumor-associated antigen in urine of patients diagnosed with bladder cancer.
MnemonicUnique test identifier.
BT REQUEST
MethodologyProcess(es) used to perform the test.
Qualitative Immunoassay
PerformedDays of the week the test is performed.
Mon-Fri
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
1-5 days
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Collect
Voided urine or urine from a catheterized patient.
Specimen Preparation
Transfer 2 mL urine to an ARUP Standard Transport Tube.
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Do not use paper or foam cups for urine specimen collection or storage.
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Results of this test should not be interpreted as absolute evidence of the presence or absence of bladder cancer. Any disease that would cause endogenous human complement factor H (hCFH) to leak into the bladder can cause a positive test result. Positive results have been associated with renal stones, nephritis, renal cancer (including upper tract TCC), urinary tract infections, cystitis, sexually transmitted diseases and recent trauma to the bladder or urinary tract. This test should not be used as a screening test for individuals without biopsy-confirmed bladder cancer. The result from the BTA stat test should be used only in conjunction with information available from the clinical evaluation of the patient and other diagnostic procedures.
Compliance Category
FDA
NoteAdditional information related to the test.
Hotline History
N/A
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.